DNAPrint genomics' Forensics Technology Featured in Presentation to Florida Sex Crimes Investigators Association SARASOTA, Fla., July 18 /PRNewswire-FirstCall/ -- DNAPrint genomics, Inc. (OTC:DNAG) (BULLETIN BOARD: DNAG) today announced that the Company's DNAWitness(TM) forensics technology was featured during a presentation at the annual conference of the Florida Sex Crimes Investigators Association annual conference in Orlando. Dr. Matthew Thomas, Ph.D., a scientist at DNAPrint genomics, provided the conference an overview on Thursday, July 14, of how DNAWitness technology can be applied to modern criminal investigations, including investigation of sex crimes. "DNAWitness is a valuable forensics tool for analyzing DNA recovered at a crime scene because it narrows the search for persons of interest, reducing cost and time in making a potential apprehension," Dr. Thomas said. "DNAWitness is the only testing method available with predictive capability that can identify the percentage of a person's genetic makeup among four possible groups -- Sub-Saharan African, Native American, East Asian and Indo- European. We also have introduced a further expansion of these four genetic groups to include Northern European, Mediterranean, Middle Eastern and Southeast Asian. In addition, recent upgrades in our technology enable DNAPrint genomics to deal with high-volume cases at less cost." Dr. Thomas noted that another tool in DNAPrint's forensics arsenal is RETINOME(TM), a new genetic test that infers eye (iris) color from DNA. "These are cutting-edge technologies that enable police to identify persons of interest more quickly," he said. "Law enforcement agencies worldwide have utilized DNAWitness to investigate more than 100 crimes and to identify the bodies of missing persons." Statistical data on sexual assaults in the U.S. vary, depending on how they are categorized. Authorities estimate there are anywhere from 200,000 to 250,000 or more incidents of rape per year, with one in three going unreported. "Serial or aggravated rape in many instances eventually leads to a murder, so catching these perpetrators early, potentially could be a lifesaver," Dr. Thomas said. "We are pleased that Florida is taking the lead in highlighting the use of DNAWitness in criminal investigations while the rest of the forensics community, for the most part, is still being supported by research dollars to develop technologies that are four to five years out," said DNAPrint President and Chief Executive Officer Richard Gabriel. "Our technology works, and it is available now." The Florida Sex Crimes Investigators Association was incorporated as a non-profit organization in April 1992 by a small, dedicated group of law enforcement investigators committed to providing low-cost, high-quality training opportunities for its members, and a means of networking and intelligence and information exchange. Today, there are more than 300 members. The website http://www.fscia.org/ contains information of interest to investigators and prosecutors of sex crimes and child abuse, as well as those who provide services for victims of such crimes. It may be used also as a resource for the general public who may have questions related to the subject matter. About DNAPrint genomics, Inc. DNAPrint genomics, Inc. ( http://www.dnaprint.com/ ) is a developer of genomics-based products and services focused on drug development, pharmacogenomic diagnostic tests, forensics technology and consumer genetic tests. Forward-Looking Statements All statements in this press release that are not historical are forward- looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Company Contact: Richard Gabriel CEO and President 941 366-3400 -or- Ron Stabiner The Wall Street Group, Inc. 212-888-4848 DATASOURCE: DNAPrint genomics CONTACT: Richard Gabriel, CEO and President, DNAPrint genomics, +1-941-366-3400; or Ron Stabiner, The Wall Street Group, Inc., +1-212-888-4848, for DNAPrint genomics Web site: http://www.dnaprint.com/ http://www.fscia.org/

Copyright